Quinbolone (Anabolicum Vister) is an anabolic steroid with weak androgenic effects. It was developed by Parke-Davis in an attempt to create a viable orally-administered anabolic steroid with little or no liver toxicity. The drug is atypical in that steroid molecules are usually only given officially distinct names when there is a permanent structural difference between the parent molecule and itself.
This page contains content from the copyrighted Wikipedia article "Quinbolone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
